Each batch should be reviewed using its own analytical record.
HPLC is used to estimate purity by separating components within a sample under defined test conditions.
Reported purity reflects relative peak area and should be interpreted within the context of the method used. It is not a standalone measure of overall quality.
Mass spectrometry is used to confirm molecular identity by verifying that the measured mass matches the expected peptide profile.
This provides identity confirmation at the batch level and complements chromatographic analysis.
HPLC and MS are used together to evaluate each batch:
Peptides are produced using solid-phase peptide synthesis (SPPS), followed by cleavage, purification, and lyophilization into a stable powder.
Lyophilized material requires reconstitution with an appropriate solvent prior to laboratory use.
Purity refers to the proportion of the target peptide sequence relative to detectable impurities within the sample.
Reported purity depends on:
A single purity percentage should not be used in isolation.
Potential impurities may include:
Endotoxins are not removed through standard purification and require separate testing methods for detection. Variability between batches can occur due to synthesis efficiency, purification thresholds, and handling conditions.
Each batch is documented with a Certificate of Analysis (CoA), which serves as the primary record for evaluation.
Each batch is associated with a Certificate of Analysis (CoA) that ties analytical findings to that specific lot.
CoAs typically include:
All conclusions about a batch should be based on its associated CoA.
All materials are supplied for in-vitro research use only.
Products are provided in lyophilized form and require reconstitution prior to use. No dosing instructions or application guidance are provided.
These materials are not approved for human or animal use and are not intended for diagnostic or therapeutic purposes.
Quality assessment depends on reviewing the data tied to a specific batch.
Material should not be evaluated based on product name alone. Each lot must be assessed using its documented analytical results.
Batch documentation provides the data needed to evaluate identity, purity, and consistency.
Confirm the lot or batch number.
Review HPLC data for purity profile.
Verify identity using mass spectrometry.
Evaluate supporting data such as endotoxin or sterility testing where applicable.
Analytical methods, manufacturing details, and batch-specific records should be read together when evaluating research material quality.
